Targeting Trypanosoma brucei FPPS by Fragment-based drug discovery

Targeting Trypanosoma brucei FPPS by Fragment-based drug discovery

Trypanosoma brucei (T. brucei) is the causative agent of the Human African Trypanosomiasis (HAT), which is a neglected disease with an endemic occurrence in 36 sub-Saharan African countries. The current standard of care suffers from low efficacy and severe side effects. Therefore, new drugs with bet...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Kaituhi matua: Münzker Lena
Ētahi atu kaituhi: Klebe, Gerhard (Prof. Dr.) (BetreuerIn (Doktorarbeit))
Hōputu: Dissertation
Reo:Ingarihi
I whakaputaina: Philipps-Universität Marburg 2019
Ngā marau:
Pharmakologie, Therapeutik
Farnesylpyrophosphat-Synthase
Trypanosoma brucei
Fragment-basierte Wirkstoffentwicklung
farnesyl pyrophosphate synthase
Fragment-based drug discovery
Pharmacology & therapeutics, prescription drugs
Urunga tuihono:Kuputuhi katoa PDF
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ngā tūemi rite